Description
Seventy million people have epilepsy with 34–76 per 100,000 developing the condition every year. To formulate rational treatment plans, it is important to understand the different clinical courses and patterns of response to antiepileptic drugs, ideally by following outcomes from the point of treatment initiation.
This project will perform analysis focusing on patients presenting with first seizure and their response to the initial therapies and their relationship with long-term treatment outcomes and development of pharmacoresistance in newly treated epilepsy patients. The student will be involved in recruiting and following up eligible patients. This project is suitable for students with background in biomedical science and/or biostatistics.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
seizure, epilepsy, outcomes, physiology, pharmacology, microbiology, anatomy, developmental biology, molecular biology, biochemistry, immunology, human pathology, clinical, neuroscience
School
School of Translational Medicine » Neuroscience
Available options
PhD/Doctorate
Masters by research
Honours
BMedSc(Hons)
Time commitment
Full-time
Top-up scholarship funding available
No
Physical location
Alfred Research Alliance
Co-supervisors
Dr
Zhibin Chen